{"id":"W4417012091","doi":"10.1182/blood-2025-5479","title":"Zilovertamab vedotin plus R-CHP versus R-CHOP for first-line treatment of diffuse large B-cell lymphoma: The phase 3 waveline-010 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Brentuximab vedotin; Prednisone; Diffuse large B-cell lymphoma; International Prognostic Index; Phases of clinical research; Lymphoma; Neutropenia; Bendamustine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00168472,0.001247863,0.00139132,0.0002853182,0.0002636967,0.001072495,0.001011525,0.001123361,0.004939269],"category_scores_gemma":[0.001059899,0.0004648883,0.00219427,0.000286282,0.0004991447,0.000830291,0.0002995587,0.003164283,0.001100195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001099599,"about_ca_system_score_gemma":0.0009554269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023299,"about_ca_topic_score_gemma":0.002356208,"domain_scores_codex":[0.9996251,0.000187345,0.0000213832,0.00006363171,0.00004056486,0.00006202812],"domain_scores_gemma":[0.999173,0.0001585262,0.0002448635,0.00006441062,0.00007673939,0.0002824018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.896697,0.02300473,0.003880869,0.001404914,0.003063139,0.00007889382,0.0001236863,0.000914701,0.009985186,0.0002075105,0.005977777,0.05466158],"study_design_scores_gemma":[0.7831851,0.1972849,0.01264659,0.0001141704,0.001613755,0.0001636623,0.00005207061,0.000970764,0.001113274,0.0002248458,0.002600904,0.00002994887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820993,0.007715203,0.0006213578,0.0008612379,0.0003076654,0.002442839,0.002895294,0.0001322318,0.00292478],"genre_scores_gemma":[0.9830662,0.003690226,0.001365898,0.001937691,0.0003174913,0.002714462,0.00363948,0.00004175373,0.0032269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004939269,"threshold_uncertainty_score":0.01652348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02706502189159616,"score_gpt":0.3250178730099192,"score_spread":0.297952851118323,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}